Core Viewpoint - The company Awei Technology (688067.SH) has announced an investment of 10 million yuan in Luying Technology, acquiring a 9.0744% stake in the latter [1] Company Summary - Awei Technology is investing its own funds to enhance its stake in Luying Technology, indicating a strategic move to strengthen its position in the high-end medical imaging sector [1] - Luying Technology specializes in the development of domestically produced high-resolution single-photon emission computed tomography (SPECT) and its core components, providing advanced molecular imaging diagnostic solutions for hospitals [1] Industry Summary - The core products of Luying Technology include domestically produced SPECT and SPECT/CT systems, which are categorized as high-end nuclear medicine imaging and diagnostic equipment [1]
爱威科技(688067.SH)拟1000万元增资麓影科技 其核心产品为SPECT和SPECT/CT及其核心元器件